28. Bayer, T.S. and C.D. Smolke, 2005. Programmable ligand-controlled riboregulators of eukaryotic gene expression. Nature Biotechnology 23: 337-43. Epub: 2005 Feb 20. 29. Dhanasekaran, M., S. Negi, and Y. Sugiura, 2006. Designer zinc finger proteins: tools for
creating artificial DNA-binding functional proteins. Accounts of Chemical Research 39: 45-52. 30. Beltran, A., et al., 2006. Interrogating genomes with combinatorial artificial transcription
factor libraries: asking zinc finger questions. Assay and Drug Development Technologies 4: 317-331.
31. Blancafort, P., D.J. Segal, and C.F. Barbas III, 2004. Designing transcription factor architectures for drug discovery. Molecular Pharmacology 66: 1361-1371.
32. Jamieson, A.C., J.C. Miller, and C.O. Pabo, 2003. Drug discovery with engineered zinc-finger proteins. Nature Reviews Drug Discovery 2: 361-368.
33. Kaiser, J., 2005. Putting the fingers on gene repair. Science 310: 1894-11896.
34. Papworth, M., P. Kolasinska, and M. Minczuk, 2006. Designer zinc-finger proteins and their applications. Gene 366: 27-38.
35. Porteus, M.H. and D. Carroll, 2005. Gene targeting using zinc finger nucleases. Nature
Biotechnology 23: 967-973.
36. Segal, D.J., et al., 2003. Evaluation of a Modular Strategy for the Construction of Novel Polydactyl Zinc Finger DNA-Binding Proteins. Biochemistry 42: 2137-2148.
37. Urnov, F.D., 2005. Highly efficient endogenous human gene crrection using designed zinc- finger nucleases. Nature 435: 646-651.
38. Lombardo, A., et al., 2007. Gene editing in human stemm cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nature Biotechnology 25: 1298-1306. 39. Howard, P.L., et al., 2003. Redirecting tyrosine kinase signaling to an apoptotic caspase
pathway through chimeric adaptor proteins. Proceedings of the National Academy of Sciences
of the United States of America 100: 11267-11272.
40. Yeh, B.J. and W.A. Lim, 2007. Synthetic biology: lessons from the history of synthetic organic chemistry. Nature Chemical Biology 3: 521-525.
41. Kaminski, P.-A. and P. Marliere, Method for the in vivo modification of the synthesis activity of
a metabolite by means of the modification of a gene the activitiy of which is not theoriginal activity 2004, Institut Pasteur.
42. Sismour, A.M., et al., 2004. PCR amplification of DNA containing non-standard base pairs by variants of reverse transcriptase from Human Immunodeficiency Virus-1. Nucleic Acids
Research 32: 728-35. Epub: 2004 Feb 02.
43. Bishop, A., et al., 2000. Unnatural ligands for engineered proteins: New tools for chemical genetics. Annual Review of Biophysics and Biomolecular Structure 29: 577–606.
44. Filipovska, A. and O. Rackham, 2008. Building a parallel metabolism within the cell. ACS
Chemical Biology 3: 51-63.
45. Balagadde, F.K., et al., 2005. Long-term monitoring of bacteria undergoing programmed population control in a microchemostat. Science 309: 137-140.
46. Lartigue, C., et al., 2007. Genome transplantation in bacteria: changing one species to another. Science 317: 632-638.
47. Smith, H.O., et al., 2003. Generating a synthetic genome by whole genome assembly: X174 bacteriophage from synthetic oligonucleotides. Proceedings of the National Academy of
Sciences of the United States of America 100: 15440-15445.
48. Gibson, D.G., et al., 2008. Complete chemical synthesis, assembly, and cloning of a
Mcyoplasma genitalium genome. Science in press.
49. Kunkel, T.A., 2004. DNA replication fidelity. Journal of Biological Chemistry 279: 16895– 16898.
50. Sanger, F., S. Nicklen, and A.R. Coulson, 1977. DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences of the United States of America 74: 5463-5467.
51. Margulies, M., et al., 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437: 376-380.
52. Ro, D.K., et al., 2006. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440: 940-943.
53. Kodumal, S.J., et al., 2004. Total synthesis of long DNA sequences: synthesis of a contiguous 32-kb polyketide synthase gene cluster. Proceedings of the National Academy of Sciences of the
United States of America 101: 15573-15578.
54. Tian, J., et al., 2004. Accurate multiplex gene synthesis from programmable DNA microchips.
Nature 432: 1050-1054.
55. Greger, B. and B. Kemper, 1998. An apyrimidinic site kinks DNA and triggers incision by endonuclease VII of phage T4. Nucleic Acids Research 26: 4432-4438.
56. Smith, J. and P. Modrich, 1997. Removal of polymerase-produced mutant sequences from PCR products. Proceedings of the National Academy of Sciences of the United States of America
94: 6847-6850.
57. Cello, J., A.V. Paul, and E. Wimmer, 2002. Chemical synthesis of poliovirus cDNA: Generation of infectious virus in the absence of natural template. Science 297: 1016-1018.
58. Agarwal, K.L., et al., 1970. Total synthesis of the gene for an alanine transfer ribonucleic acid from yeast. Nature 227: 27-34.
59. Itakura, K., et al., 1977. Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 198: 1056-1063.
60. Khorana, H.G., 1979. Total synthesis of a gene. Science 203: 614-625.
61. Tumpey, T.M., et al., 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus Science 310: 77-80.
62. Kobasa, D., et al., 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445: 319-323.
63. Larionov, V., et al., 1996. Specific cloning of human DNA as yeast artificial chromosomes by transformation-associated recombination. Proceedings of the National Academy of Sciences of
the United States of America 93: 491-496.
64. Itaya, M., et al., 2005. Combining two genomes in one cell: Stable cloning of the Synechocystis PCC6803 genome in the Bacillus subtilis 168 genome. Proceedings of the National Academy of
Sciences of the United States of America 102: 15971-15976.
65. Itaya, M., et al., 2008. Bottom-up genome assembly using the Bacillus subtilis genome vector.
Nature Methods 5: 41-43.
66. Carlson, R., 2003. The pace and proliferation of biological technologies. Biosecurity and
Bioterrorism 1: 203-14.
67. von Heeren, F., et al., 1996. Micellar electrokinetic chromatography separations and analyses of biological samples on a cyclic planar microstructure. Analytical Chemistry 68: 2044-2053. 68. Lichtenberg, J.B.H. and H. Baltes, Nanofluidics - structures and devices, in Enabling
Technologies for MEMS and Nanodevices, B. H., et al., Editors. 2004, Wiley-VCH. p. 319-356.
69. Hong, J.W., et al., 2006. Molecular biology on a microfluidic chip. Journal of Physics-
Condensed Matter 18: S691-S701.
70. Gomez-Sjöberg, R., et al., 2007. Versatile, fully automated, microfluidic cell culture system.
Analytical Chemistry 79: 8557-8563.
71. Marcy, Y., et al., 2007. Dissecting biological ‘‘dark matter’’ with single-cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth. Proceedings of the National
Academy of Sciences of the United States of America 104: 11889–11894.
72. Maerkl, S.J. and S.R. Quake, 2007. A systems approach to measuring the binding energy landscapes of transcription factors. Science 315: 233-237.
73. Hong, J.W., et al., 2004. A nanoliter-scale nucleic acid processor with parallel architecture.
Nature Biotechnology 22: 435-439.
74. Northrup M.A., C.R.M., Watson R.T. DNA amplification with a microfabricated reaction
chamber. in Proceedings of the 7th international conference on solid state sensors and actuators. 1993. Yokohama, Japan.
75. Kopp, M.U., A.J. de Mello, and A. Manz, 1998. Chemical amplification: Continuous-flow PCR on a chip. Science 280: 1046-1048.
76. Liu, J., C. Hansen, and S.R. Quake, 2003. Solving the "world-to-chip" interface problem with a microfluidic matrix. Analytical Chemistry 75: 4718-4723.
77. Geschke, O., H. Klank, and P. Tellermann, Microsystem Engineering of Lab-on-a-Chip Devices. 2004, Weiheim: Wiley-VCH.
78. Engström J., I.M., Ekstrand G., Eckersten A., Dérand H., Lindman S., Andersson P.; Gyros AB, Uppsala, Sweden. Quantitative bioaffinity assays of crude protein mixtures performed at
nanoliter scale in a CD microlaboratory. in HPCE 2002. HPCE 2002, Stockholm, Sweden.
79. Marcus, J.S., W.F. Anderson, and S.R. Quake, 2006. Microfluidic single-cell mRNA isolation and analysis. Analytical Chemistry 78: 3084-3089.
80. Zhong, J.F., et al., 2008. A microfluidic processor for gene expression profiling of single human embryonic stem cells. Lab on a Chip 8: 68–74.
81. Elowitz, M.B. and S. Leibler, 2000. A synthetic oscillatory network of transcriptional regulators. Nature 403: 335-338.
82. de Lorenzo, V., et al., 1993. Engineering of alkyl- and haloaromatic-responsive gene
expression with mini-transposons containing regulated promoters of biodegradative pathways of Pseudomonas. Gene 130: 41-46.
83. Herrero, M., et al., 1993. A T7 RNA polymerase-based system for the construction of
Pseudomonas strains with phenotypes dependent on TOL-meta pathway effectors. Gene 134:
103-106.
84. Knight, T., Idempotent vector design for standard assembly of biobricks, in MIT Synthetic Biology Working Group Technical Reports. 2003, MIT Artificial Intelligence Laboratory. p. doi:
1721.1/21168.
85. Sprinzak, D. and M.B. Elowitz, 2005. Reconstruction of genetic circuits. Nature 438: 443-448. 86. Gardner, T.S., C.R. Cantor, and J.J. Collins, 2000. Construction of a genetic toggle switch in
Escherichia coli. Nature 403: 339-342.
87. Elowitz, M.B., et al., 2002. Stochastic gene expression in a single cell. Science 297: 1183- 1186.
88. Rosenfeld, N., et al., 2005. Gene regulation at the single-cell level. Science 307: 1962-1965. 89. Basu, S., et al., 2004. Spatiotemporal control of gene expression with pulse-generating
networks. Proceedings of the National Academy of Sciences of the United States of America 101: 6355-6360.
90. Kramer, B.P. and M. Fussenegger, 2005. Hysteresis in a synthetic mammalian gene network.
Proceedings of the National Academy of Sciences of the United States of America 102: 9517-
9522.
91. Rosenfeld, N., et al., 2007. Accurate prediction of gene feedback circuit behavior from component properties. Molecular Systems Biology 3: 143.
92. Khlebnikov, A., et al., 2001. Homogeneous expression of the PBAD promoter in Escherichia coli by constitutive expression of the low-affinity high-capacity AraE transporter. Microbiology
147: 3241-3247.
93. Ozbudak, E.M., et al., 2004. Multistability in the lactose utilization network of Escherichia
coli. Nature 427: 737-740.
94. Anderson, J.C., et al., 2006. Environmentally controlled invasion of cancer cells by engineered bacteria. Journal of Molecular Biology 355: 619-627.
95. Yokobayashi, Y., R. Weiss, and F.H. Arnold, 2002. Directed evolution of a genetic circuit.
Proceedings of the National Academy of Sciences of the United States of America 99: 16587-
16591.
96. Martin, V.J.J., et al., 2003. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature Biotechnology 21: 796-802.
97. Pfleger, B.F., et al., 2006. Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes. Nature Biotechnology 24: 1027-1032.
98. Park, S.-Y., A. Zarrinpar, and W.A. Lim, 2003. Rewiring MAP kinase pathways using alternative scaffold assembly mechanisms. Science 299: 1061-1064.
99. Menzella, H.G., et al., 2005. Combinatorial polyketide biosynthesis by de novo design and rearrangement of modular polyketide synthase genes. Nature Biotechnology 23: 1171-1176. 100. Chandran, S.S., et al., 2006. Activating hybrid modular interfaces in synthetic polyketide
synthases by cassette replacement of ketosynthase domains. Chemistry & Biology 13: 469– 474.
101. Menzella, H.G., J.R. Carney, and D.V. Santi, 2007. Rational design and assembly of synthetic trimodular polyketide synthases. Chemistry & Biology 14: 143–151.
102. Koonin, E.V., 2000. How many genes can make a cell: The minimal-gene-set concept. Annual
Review of Genomics and Human Genetics 1: 99-116.
103. Kitano, H., 2004. Biological robustness. Nature Reviews Genetics 5: 826-837.
104. Gil, R., et al., 2004. Determination of the core of a minimal bacterial gene set. Microbiology
and Molecular Biology Reviews 68: 518-537.
105. Hutchison III, C.A., et al., 1999. Global transposon mutagenesis and a minimal Mycoplasma genome. Science 86: 2165-2169.
106. Glass, J.I., et al., 2006. Essential genes of a minimal bacterium. Proceedings of the National
Academy of Sciences of the United States of America 103: 425-430.
107. Kobayashi, K., et al., 2003. Essential Bacillus subtilis genes. Proceedings of the National
Academy of Sciences of the United States of America 100: 4678–4683.
108. Posfai, G., et al., 2006. Emergent properties of reduced-genome Escherichia coli. Science 312: 1044-1046.
109. Glass, J.I., et al., Minimal bacterial genome, U. PTO, Editor. 2007, J. Craig Venter Institute. 110. Yu, B.J., et al., 2002. Minimization of the Escherichia coli genome using a Tn5-targeted
Cre/loxP excision system. Nature Biotechnology 20: 1018-1023.
111. Goryshin, I.Y., et al., 2003. Chromosomal Deletion Formation System Based on Tn5 Double Transposition: Use For Making Minimal Genomes and Essential Gene Analysis. Genome
Research 13: 644-653.
112. Hashimoto, M., et al., 2005. Cell size and nucleoid organization of engineered Escherichia coli cells with a reduced genome. Molecular Microbiology 55: 137-149.
113. Kolisnychenko, V., et al., 2002. Engineering a reduced Escherichia coli genome. Genome
Research 12: 640-647.
114. Sharma, S.S., et al., 2007. Expression of two recombinant chloramphenicol acetyltransferase variants in highly reduced genome Escherichia coli strains. Biotechnology and Bioengineering
98: 1056-1070.
115. Sharma, S.S., F.R. Blattner, and S.W. Harcum, 2007. Recombinant protein production in an
Escherichia coli reduced genome strain. Metabolic Engineering 9: 133-141.
116. Mizoguchi, H., H. Mori, and T. Fujio, 2007. Escherichia coli minimum genome factory.
Biotechnology and Applied Biochemistry 46: 157-167.
117. Westers, H., et al., 2003. Genome engineering reveals large dispensable regions in Bacillus
subtilis. Molecular Biology and Evolution 20: 2076-2090.
118. Ara, K., et al., 2007. Bacillus minimum genome factory: effective utilization of microbial genome information. Biotechnology and Applied Biochemistry 46: 169–178.
119. Brazma, A., et al., 2001. Minimum information about a microarray experiment (MIAME)- toward standards for microarray data. Nature Genetics 29: 365 - 371.
120. Hucka, M., et al., 2003. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19: 524-531. 121. Le Novere, N., et al., 2005. Minimum information requested in the annotation of biochemical
models (MIRIAM) Nature Biotechnology 23: 1509 - 1515.
122. Henkel, J. and S. Maurer, 2007. The economics of synthetic biology. Molecular Systems
Biology 3: 117.
123. Rai, A. and J. Boyle, 2007. Synthetic Biology:Caught between property rights, the public domain, and the commons. PLOS Biology 5: e58.
124. Blattner, F.R., et al., Bacteria with reduced genome, PTO, Editor. 2003, Wisconsin Alumni Research Foundation.
125. ETC_Group, Extreme genetic engineering. 2007. p.
http://www.etcgroup.org/en/materials/publications.html?id=602.
126. de Vriend, H., Constructing life: Early social reflections on the emerging field of synthetic
biology. 2006, The Rathenau Institute. p.
http://www.rathenauinstituut.com//showpage.asp?steID=2&item=1288&searching=construc ting%20life.
127. Tucker, J.B. and R.A. Zilinskas, 2006. The promise and perils of synthetic biology. The New
128. Kramer, B.P., et al., 2004. An engineered epigenetic transgene switch in mammalian cells.
Nature Biotechnology 22: 867-870.
129. Randerson, J., Revealed: the lax laws that could allow assembly of deadly virus DNA, in The Guardian. 2006. p. http://www.guardian.co.uk/world/2006/jun/14/terrorism.topstories3.
130. Agency, C.I., The darker bioweapons future. 2003, Central Intelligence Agency. p.
http://www.fas.org/irp/cia/product/bw1103.pdf. 131. Brent, R., 2006. Power and responsibility.
132. Fink, G., et al., Biotechnology research in an age of terrorism: confronting the dual use
dilemma. 2003, Committee on Research Standards and Practices to Prevent the Destructive
Application of Biotechnology - National Research Council of the National Academies. 133. Garfinkel, M.S., et al., Synthetic Genomics - Options for Governance. 2007.
134. Kelle, A., Synthetic Biology & Biosecurity Awareness In Europe, in Bradford Science and Technology Reports. 2007, University of Bath.
135. Bügl, H., et al., 2007. DNA synthesis and biological security. Nature Biotechnology 25: 627- 629.
136. Cho, M.K., et al., 1999. Ethical considerations in synthesizing a minimal genome. Science